SHANGHAI, May 27, 2026 /PRNewswire/ — Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted and granted priority review to the New Drug Application (NDA) for ZEGFROVY^® (sunvozertinib) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins).

ZEGFROVY was granted accelerated approval previously by China’s CDE and the U.S. Food and Drug Administration (FDA). The new sNDA is based on the results of WU-KONG28 study, a confirmatory, multinational, randomized phase 3 study evaluating ZEGFROVY versus platinum-containing chemo doublet as first-line treatment in advanced NSCLC patients with EGFR exon20ins. The study met its primary endpoint with statistically significant and clinically meaningful improvement in Progression Free Survival (PFS). The detailed data will be presented as a Late-Breaking Abstract (LBA) oral presentation at the upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

“The NDA acceptance and priority review designation for ZEGFROVY in first-line EGFR exon20ins NSCLC is an important step forward for us to make the drug available to our patients globally,” said Dr. Xiaolin Zhang, CEO of Dizal. “Supported by positive results from WU-KONG28, we believe ZEGFROVY has the potential to be a practice-changing drug for this underserved patient population. We are working very hard to submit NDAs to other regulatory agencies globally as soon as possible.”

Lung cancer with EGFR exon20ins are particularly challenging to treat due to its high heterogeneity. Currently, the first-line treatment for EGFR exon20ins NSCLC largely relies on chemotherapy-based regimens. There remains an unmet need for effective, chemotherapy-free, oral targeted therapies for newly diagnosed patients.

Globally, no oral targeted therapies have been approved for the first-line treatment of EGFR exon20ins NSCLC. ZEGFROVY monotherapy has received Breakthrough Therapy Designations (BTDs) from both the U.S. FDA and China’s CDE for this treatment-naïve patient population.

About ZEGFROVY^®(sunvozertinib)
ZEGFROVY is an irreversible EGFR inhibitor discovered by Dizal scientists targeting a wide spectrum of EGFR mutations with wild-type EGFR selectivity. ZEGFROVY is approved in the U.S. and China for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), whose disease has progressed on or after platinum-based chemotherapy. The approval in China is based on the results of the pivotal WU-KONG6 study in platinum-based chemotherapy pretreated NSCLC with EGFR exon20ins. The U.S. approval is supported by WU-KONG1 Part B, a multinational pivotal study investigating the efficacy and safety of ZEGFROVY in the same indication.

In addition, ZEGFROVY also demonstrated encouraging anti-tumor activity in NSCLC patients with EGFR sensitizing, T790M, and uncommon mutations, as well as HER2 exon20ins.

ZEGFROVY showed a well-tolerated and manageable safety profile in the clinic. The most common drug-related TEAEs (treatment-emergent adverse event) were Grade 1/2 in nature and clinically manageable.

WU-KONG28, a multinational, randomized Phase 3 study conducted across 16 countries and regions evaluating ZEGFROVY as first-line treatment for patients with EGFR exon20ins NSCLC, met its primary endpoint.

Pre-clinical and clinical results of ZEGFROVY were published in peer-reviewed journals including Cancer Discovery, The Lancet Respiratory Medicine and Journal of Clinical Oncology.

About Dizal
Dizal is a biopharmaceutical company, dedicated to the discovery, development and commercialization of differentiated therapeutics for the treatment of cancer and immunological diseases. The company aims to develop first-in-class and groundbreaking new medicines, and further address unmet medical needs worldwide. Deep-rooted in translational science and molecular design, it has established an internationally competitive portfolio with multiple assets in global pivotal studies and two leading assets: ZEGFROVY, approved in both the U.S. and China, and golidocitinib, approved in China. To learn more about Dizal, please visit www.dizalpharma.com, or follow us on LinkedIn or X.

Forward-Looking Statements
This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, and “intend” and similar expressions, as they relate to Dizal, are intended to identify certain forward-looking statements. Dizal does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections, and understandings of the management of Dizal with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties, and other factors, some of which are beyond Dizal’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Dizal’s competitive environment, and political, economic, legal, and social conditions.

Dizal, the Directors, and the employees of Dizal assume (a) no obligation to correct or update the forward-looking statements contained on this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect.

Contacts
Investor Relations: ir@dizalpharma.com
Business Development: bd@dizalpharma.com
Media Contact: pr@dizalpharma.com 

ABU DHABI, UAE, May 27, 2026 /PRNewswire/ — Yi He, Co-CEO and Co-Founder of Binance, has been named to Fortune’s annual Most Powerful Women in Business list in 2026, becoming the first crypto-native executive to appear on the global ranking. The recognition places her among 100 of the world’s most influential women in business leaders and marks a milestone for the digital asset industry as it becomes more deeply integrated into the global economy.

Fortune’s Most Powerful Women list is one of the most established and closely watched rankings in global business. It has traditionally featured leaders from major multinational corporations and long-standing institutions. Yi’s debut on the list this year reflects both the growing influence of crypto and Binance’s role in shaping the future of finance and technology.

Yi has shaped Binance from the start. She co-founded the company in 2017 and has been central to its product vision, culture, and user-first approach ever since. In December 2025, she was appointed Co-CEO alongside Richard Teng, creating a dual-leadership structure that pairs her strategic and product expertise with his regulatory and operational leadership. Together, they guide Binance’s global strategy as the company enters its next phase of growth.

“Being named to Fortune’s Most Powerful Women list feels meaningful — not just for me, but for crypto as a whole,” said Yi He. “A few years ago, a founder from this industry showing up on a list like this would have been unusual. Today, it reflects how far we’ve come: from the edge of finance toward the center of how the world actually works.”

Yi’s path to this recognition is far from conventional. She grew up in a rural village in Sichuan without running water or electricity. At sixteen, she worked in a supermarket. She later became a television host, entered the tech industry, and taught herself English in her thirties before co-founding Binance. Within the crypto community, she is affectionately known as Binance’s ‘chief customer service officer.’ It is a reflection of the user-first philosophy that has defined her leadership.

This latest recognition also reflects the scale of the platform she helped build. Binance today serves more than 310 million registered users globally and remains the world’s leading blockchain ecosystem and digital asset infrastructure provider. In 2025 alone, the platform processed $34 trillion in trading volume, bringing its cumulative all-time volume to $145 trillion by the end of 2025. The company is also expanding beyond crypto into a broader range of asset classes and financial services, consistent with its vision of building a financial super app for the digital economy.

“I’m honored by this recognition, and it only deepens my commitment to the 310 million people who place their trust in Binance every day — including a son in Nairobi sending wages home to his mother, and a woman in a small Indian city opening her first account at fifty. Finance has never been equally kind to everyone, and that trust is something we have to earn every day. I have never thought of my role as simply running a company. I think about how we serve the people the old system left behind — many of them women, many of them in places the world doesn’t always look at first.”

“Three hundred and ten million is a number we’re grateful for. It’s also a small fraction of the people this industry was built to serve. We’re working toward three billion — roughly everyone still outside the formal financial system today. A future where money moves as freely as information, where people, software, and AI agents share the same open economy, where no one needs permission to take part. That vision is what keeps me going. In many ways, it still feels like day one.”

Yi’s inclusion on Fortune’s list signals a broader shift in global business. Crypto is no longer seen only as an emerging sector. It is increasingly recognized as a force shaping finance, technology, and economic participation worldwide. Her recognition also expands the picture of what leadership can look like, creating greater visibility for women and founders from non-traditional backgrounds.

“In its 29th year, this iconic list of powerful women includes almost half from outside of the U.S., reminding us that the impact of women leadership is being seen globally,” said Alyson Shontell, Fortune Editor in Chief and Chief Content Officer in its official list reveal release. “These are women transforming business today and preparing for a future during a time of tumult and uncertainty, but also great promise.”

About Binance

Binance is a leading global blockchain ecosystem behind the world’s largest cryptocurrency exchange by trading volume and registered users. Binance is trusted by more than 310 million people in 100+ countries for its industry-leading security, transparency, trading engine speed, protections for investors, and unmatched portfolio of digital asset products and offerings from trading and finance to education, research, social good, payments, institutional services, and Web3 features. Binance is devoted to building an inclusive crypto ecosystem to increase the freedom of money and financial access for people around the world with crypto as the fundamental means. For more information, visit: https://www.binance.com

YOKOHAMA, Japan, May 27, 2026 /PRNewswire/ — NOVOSENSE (688052.SH | 02676.HK) is exhibiting at Automotive Engineering Exposition 2026, held from May 27 to 29 at PACIFICO Yokohama, Booth No. 206. NOVOSENSE presents its automotive-grade automotive semiconductor solutions for xEV powertrain, ADAS, body electronics and lighting applications.

For ADAS, NOVOSENSE highlights video transmission and ultrasonic sensing technologies for vehicle safety and auto-parking. Its NLS911x serializer and NLS924x deserializer automotive SerDes chipset, based on the HSMT open protocol, supports links up to 6.4 Gbps for low-latency transmission of multi-channel HD signals. The NSUC1800 ultrasonic sensor interface IC is designed for UPA, APA, AVP and low-speed ADAS applications, combining DSI3 and AK2 compatibility with near-field detection within 10 cm, long-range detection up to 6–7 m, and compliance with ISO 26262 ASIL B and AEC-Q100. These technologies are also featured in NOVOSENSE’s exhibitor seminar, “ADAS Semiconductor Solutions Supporting Vehicle Safety and Auto-Parking,” on May 27, 13:40–14:10, at Harbor Lounge A.

For xEV power systems, NOVOSENSE focuses on isolation, gate driving and current sensing for high-voltage power conversion. The NSI6911F ASIL D isolated gate driver supports traction inverter, OBC and DC-DC applications with functional safety capability, high CMTI performance, integrated 12-bit high-precision isolated ADC and diagnostic protection. Together with NSM2311, NSM2019, NSM2015 and NSM2012 current sensors, the portfolio supports current feedback, system protection and efficient closed-loop control.

For body electronics and lighting, NOVOSENSE presents products for ambient lighting, rear lamps, thermal management, CAN FD communication and sensing. NSUC1500-Q1 and NSUC1527 support refined dimming, individual LED and multi-zone control, and music-synchronized lighting effects. NSL21912/16/24FS linear LED drivers support stable, precise and functionally safe rear lamp and body lighting control. NSUC1602/1610/1612 MCU+ products support thermal management actuator control, while NCA1462-Q1 and NCA1044-Q1 CAN FD transceivers, with VeLIO certification and European IBEE/FTZ-Zwickau EMC certification, help improve in-vehicle network reliability and reduce system verification effort.

NOVOSENSE works with Yole Group to host special insight sessions at its booth. Dr. Yu YANG, Principal Lead Analyst – Automotives & Robotics, shares trends observed at Beijing Auto 2026, including chassis and powertrain integration, L3 vs. L2/L4 convergence and 48V powernet. Pierrick BOULAY, Principal Analyst – Automotive Semiconductors,  discusses Physical AI, ADAS, key semiconductors and the future of intelligent vehicles.

NOVOSENSE’s automotive business continues to expand. In 2025, the company reported approximately US$495 million in revenue, with automotive contributing over 35%. Annual automotive chip shipments exceeded 750 million, bringing cumulative shipments to more than 1.418 billion. In Q1 2026, revenue reached approximately US$168 million, up 59.17% year on year.

The same product portfolio will also be showcased at Automotive Engineering Exposition NAGOYA 2026, held from June 17 to 19, Booth No. 176.

Learn more: www.novosns.com

HAIKOU, China, May 27, 2026 /PRNewswire/ — A news report from chinadaily.com.cn:

The Nihao China: European Travel Media and Influencers’ Hainan Tour was officially launched in Haikou, capital of China’s southernmost Hainan province on May 25. The program is an immersive eight-day journey to explore the wonders of Hainan.

Organized by the Bureau of International Exchange and Cooperation of China’s Ministry of Culture and Tourism along with the Hainan Provincial Department of Tourism, Culture, Radio, Television and Sports, the event brings together 24 travel journalists and influencers from across Europe, including Italy, Spain, the United Kingdom, France, Germany and Switzerland.

On the evening of May 25, a Hainan Night promotional event was held in Haikou. The organizers provided the guests with an in-depth look into what makes Hainan a standout destination for international tourism and tropical island getaways. Hainan features a forest coverage of 62.1 percent, a 1,944-kilometer coastline, a 99.4-percent clear-air rate, and a visa-free policy for travelers from 86 countries.

Over the next few days, they will explore various cities and counties such as Haikou, Wenchang, Qionghai, Wanning, Baoting and Sanya. There, they’ll get firsthand experiences of Hainan’s diverse tourism offerings.

They’ll stroll through Haikou’s Qilou Old Street to soak up the historical charm of the Nanyang-style architecture, visit the Boao Lecheng International Medical Tourism Pilot Zone to learn about world-class health services, take in the scenic views of mountains and the sea from the Shimei Bay tourist highway in Wanning — and feel the tingling excitement of surfing at Riyue Bay in Wanning.

Hainan has a well-established flight network, with over 300 international flight routes through its major airports in Haikou, Sanya and Qionghai — making it easily accessible via hubs like Hong Kong, Beijing and Shanghai.

The eight-day journey aims to showcase the unique charms of sunny Hainan to a broader international audience through the perspectives of European media and bloggers.

YOKOHAMA, Japan, May 27, 2026 /PRNewswire/ — Desay SV, a leading global mobility technology company, participates in the Automotive Engineering Exposition (AEE) 2026 at Pacifico Yokohama on May 27th, 2026. Celebrating 40 years of driving smarter mobility, Desay SV presents exhibition and seminar under the anniversary theme “40 Years for Smarter Mobility”, showcasing a comprehensive portfolio of technologies designed to address the evolving needs of both the Japanese and global automotive markets.

Redefining the In-Vehicle Experience and Automated Driving

At the heart of Desay SV’s exhibition is the Flagship AI Intelligent Cabin Domain Controller Platform, EA01U. Featuring industry-first seamless cloud-edge integration, the platform offers scenario-adaptive functionalities aligned with individual user preferences to enhance the in-vehicle experience. It leverages edge-side Omni Model and Mixture of Experts (MOE) to deliver advanced voice and gesture recognition capabilities. Built on an intelligent agent interaction framework and AI OS, the solution also enables users to execute cross-device tasks seamlessly. In addition, EA01U features a scalable architecture designed for cross-domain integration across cabin, driving and parking functions.

Complementing the cabin experience, Desay SV also showcases comprehensive full-stack ADAS solution. The scalable “Hardware Platform + Software Algorithm + System Integration” suite supports functional requirements ranging from mass-market vehicles to premium models. First introduced at the Auto Shanghai 2025, the solution further demonstrates its global adaptability at IAA Mobility 2025 in Germany, where its advanced capabilities are validated through live urban and highway test drives with international industry partners.

Accelerating Intelligent and Sustainable Mobility

During the on-site seminar, Kosuke Kawasaki, Managing Director of Desay SV Japan, highlights three major challenges currently facing the automotive sector in the AI era: managing increasing user experience complexity, aligning subjective comfort expectations with technical execution, and balancing safety requirements with user convenience.

To address these challenges, Kawasaki explains that Desay SV focuses on an open development model that supports ecosystem collaboration, alongside a full-lifecycle AI operation platform integrating development and deployment processes. Through these initiatives, Desay SV aims to work closely with industry partners to evolve its value proposition from functional delivery towards integrated user experiences and deeper emotional engagement.

Localized Operations and Long-Term Commitment to Japan

Over the past 40 years, Desay SV has continuously adapted to changes in the automotive industry while advancing technological capabilities and expanding global presence. This ongoing evolution has strengthened Desay SV’s operational resilience and established a strong international customer base.

Since entering the Japanese market in 2013, Desay SV has expanded local presence to three offices in Hiroshima, Toyota and Yokohama reflecting its long-term commitment to supporting Japanese OEMs through localized engineering capabilities and partnership development.

With 26 locations worldwide and partnerships spanning more than 80 automotive brands, Desay SV continues to support vehicle manufacturers through customizable, modular “atomic” services. This global infrastructure reinforces Desay SV’s commitment to smarter mobility for all by delivering safe, delightful and sustainable mobility solutions and services to customers worldwide.